Elevation of hemoglobin A1c increases the risk of decline in left ventricular systolic function among patients with coronary artery disease

•Incidence of decline in LV systolic function increases with the elevation of HbA1c.•Elevated HbA1c is a predictor of decline in LV systolic function in CAD patients.•Decline in LV systolic function would improve the risk of cardiovascular death. The aim of this study was to investigate the associat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes & metabolism 2023-01, Vol.49 (1), p.101411-101411, Article 101411
Hauptverfasser:	Mai, Ziling, Huang, Zhidong, Li, Yuqi, Xie, Yun, Li, Huanqiang, Wang, Bo, Bai, Wei, Lai, Wenguang, Yu, Sijia, Lu, Hongyu, Han, Kedong, Chen, Xuewen, Shi, Yingming, Chen, Shiqun, Liu, Jin, Liu, Yong, Chen, Jiyan
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Clinical Studies as Topic Coronary artery disease Coronary Artery Disease - complications Female Glucose metabolism Glycated Hemoglobin Hemoglobin A1c Humans Left ventricular ejection fraction Left ventricular systolic function Male Middle Aged Registries Stroke Volume Ventricular Dysfunction, Left - complications Ventricular Function, Left
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	•Incidence of decline in LV systolic function increases with the elevation of HbA1c.•Elevated HbA1c is a predictor of decline in LV systolic function in CAD patients.•Decline in LV systolic function would improve the risk of cardiovascular death. The aim of this study was to investigate the association of HbA1c and left ventricular (LV) systolic function among patients with coronary artery disease (CAD). CAD patients from the Cardiorenal ImprovemeNt II (CIN-II, NCT05050877) registry were included in the study. They were separated into four groups based on HbA1c levels (Q1: HbA1c
ISSN:	1262-3636 1878-1780
DOI:	10.1016/j.diabet.2022.101411